Compare CRTO & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRTO | BLFS |
|---|---|---|
| Founded | 2005 | 1987 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.9M | 923.5M |
| IPO Year | 2013 | 2013 |
| Metric | CRTO | BLFS |
|---|---|---|
| Price | $17.30 | $23.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $34.00 | $32.00 |
| AVG Volume (30 Days) | 324.6K | ★ 429.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.95 | ★ 77.27 |
| EPS | ★ 0.15 | 0.02 |
| Revenue | ★ $2,296,692,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | $5.54 | $17.82 |
| P/E Ratio | ★ $114.33 | $1,235.25 |
| Revenue Growth | ★ 27.65 | 16.97 |
| 52 Week Low | $15.58 | $17.86 |
| 52 Week High | $27.48 | $29.57 |
| Indicator | CRTO | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 62.58 |
| Support Level | $16.14 | $23.74 |
| Resistance Level | $20.16 | $26.55 |
| Average True Range (ATR) | 0.82 | 1.19 |
| MACD | 0.06 | 0.27 |
| Stochastic Oscillator | 36.73 | 77.08 |
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.